| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |